Skip to content
Colorectal Cancer Clinical Trials

Jacksonville, Florida

Colorectal cancer clinical trials in Jacksonville, FL

29 colorectal cancer studies are recruiting participants at sites in Jacksonville as of November 16, 2026, according to ClinicalTrials.gov. Colorectal Cancer Clinical Trials can help you understand your options and connect with a study team.

Call (888) 385-9581
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Jacksonville at a glance

  • 29 studies are recruiting at a site in Jacksonville.
  • By phase: Phase 1 (7), Phase 1/2 (6), Phase 2 (5), Phase 2/3 (1), Phase 3 (3), No phase (2), Observational (5). Studies of devices and behavioral approaches have no phase.
  • By sponsor: industry (20), university, hospital or other (9).
  • Most recent update to one of these records: November 12, 2026.

Studies recruiting in Jacksonville

Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Study site
    Mayo Clinic in Florida ( Site 0092)
    Registry record
    NCT06997497 · updated
  2. At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Mayo Clinic
    Study site
    Mayo Clinic in Florida
    Registry record
    NCT05969860 · updated
  3. A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials

    • Observational
    • Ages 18 to 100
    • All sexes
    Sponsor
    University of Florida
    Study site
    Mayo Clinic in Florida
    Registry record
    NCT05655494 · updated
  4. Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease

    • Phase 2/3
    • Ages 18 and older
    • All sexes
    Sponsor
    NRG Oncology
    Study site
    Baptist MD Anderson Cancer Center
    Registry record
    NCT05174169 · updated
  5. A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Kumquat Biosciences Inc.
    Study site
    Mayo Clinic, Jacksonville
    Registry record
    NCT06720987 · updated
  6. Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

    • Observational
    • Ages 18 and older
    • All sexes
    Sponsor
    A2 Biotherapeutics Inc.
    Study site
    Mayo Clinic Jacksonville
    Registry record
    NCT04981119 · updated
  7. A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Artios Pharma Ltd
    Study site
    Mayo Clinic (Florida)
    Registry record
    NCT04657068 · updated
  8. KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Kura Oncology, Inc.
    Study site
    Mayo Clinic Comprehensive Cancer Center
    Registry record
    NCT06026410 · updated
  9. A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    AbbVie
    Study site
    Mayo Clinic Hospital Jacksonville /ID# 274472
    Registry record
    NCT07023289 · updated
  10. Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Pfizer
    Study sites
    Mayo Clinic · Mayo Clinic Pharmacy
    Registry record
    NCT07222800 · updated
  11. FOG-001 in Locally Advanced or Metastatic Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Parabilis Medicines, Inc.
    Study site
    Mayo Clinic
    Registry record
    NCT05919264 · updated
  12. Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Mayo Clinic
    Study site
    Mayo Clinic in Florida
    Registry record
    NCT06265285 · updated
  13. Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Exelixis
    Study site
    Exelixis Clinical Site #78
    Registry record
    NCT05176483 · updated
  14. The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Mayo Clinic
    Study site
    Mayo Clinic in Florida
    Registry record
    NCT07285044 · updated
  15. A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    AstraZeneca
    Registry record
    NCT05877599 · updated
  16. Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Revolution Medicines, Inc.
    Study site
    Mayo Clinic Cancer Center
    Registry record
    NCT06445062 · updated
  17. Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Amgen
    Study site
    Cancer Specialists of North Florida - Southpoint
    Registry record
    NCT06252649 · updated
  18. A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Cartography Biosciences
    Study site
    Mayo Clinic Florida
    Registry record
    NCT07321106 · updated
  19. Collecting Blood and Stool Samples to Detect Colorectal Cancer or Advanced Neoplasia in Lynch Syndrome Patients

    • Observational
    • Ages 18 and older
    • All sexes
    Sponsor
    Mayo Clinic
    Study site
    Mayo Clinic in Florida
    Registry record
    NCT05410977 · updated
  20. Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Xencor, Inc.
    Study site
    Xencor Investigative Site
    Registry record
    NCT05433142 · updated
  21. Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers

    • Phase 1
    • Ages 18 to 100
    • All sexes
    Sponsor
    Novartis Pharmaceuticals
    Study site
    Mayo Clinic Jacksonville
    Registry record
    NCT06562192 · updated
  22. A Study to Evaluate the Safety and Efficacy of Two Dose Levels of ONO-4578 With Opdivo®, in Combination With mFOLFOX6 and Bevacizumab Versus Standard of Care in Participants With Non-MSI-H/dMMR, PD-L1 Positive Advanced Colorectal Cancer

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Ono Pharmaceutical Co., Ltd.
    Study site
    Mayo Clinic Florida
    Registry record
    NCT06948448 · updated
  23. Smart Symptom Tracking ALEX Application for Tracking and Monitoring Gastrointestinal Health, Smart Horizons Pilot Trial

    • No phase
    • Ages 18 to 44
    • All sexes
    Sponsor
    Mayo Clinic
    Study site
    Mayo Clinic in Florida
    Registry record
    NCT07618273 · updated
  24. Intravital Microscopy in Human Solid Tumors

    • No phase
    • Ages 18 and older
    • All sexes
    Sponsor
    Mayo Clinic
    Study site
    Mayo Clinic Florida
    Registry record
    NCT03823144 · updated
  25. A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    858 Therapeutics, Inc.
    Study site
    Mayo Clinic
    Registry record
    NCT06395519 · updated
  26. Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform

    • Observational
    • Ages 18 and older
    • All sexes
    Sponsor
    Mayo Clinic
    Study site
    Mayo Clinic in Florida
    Registry record
    NCT06349642 · updated
  27. SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

    • Observational
    • All ages
    • All sexes
    Sponsor
    Massive Bio, Inc.
    Study site
    Massive Bio SYNERGY-AI site
    Registry record
    NCT03452774 · updated
  28. A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    A2 Biotherapeutics Inc.
    Study site
    Mayo Clinic
    Registry record
    NCT06682793 · updated
  29. A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    GI Innovation, Inc.
    Study site
    Mayo Clinic in Florida
    Registry record
    NCT05824975 · updated

Source: ClinicalTrials.gov. Data processed . See every colorectal cancer study recruiting in Jacksonville, FL on ClinicalTrials.gov.

Ask about studies near Jacksonville

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

More locations in Florida

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.

Colorectal Cancer Clinical Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 385-9581

or send a short form

How should we reach you?

Call